サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428179

腫瘍溶解性ウイルス治療の世界市場レポート 2024

Oncolytic Virus Therapy Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
腫瘍溶解性ウイルス治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

腫瘍溶解性ウイルス治療の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には23.9%の年間複合成長率（CAGR）で4億4,000万米ドルに成長すると予想されます。今後の成長は、腫瘍溶解性ウイルスプラットフォームの拡大、免疫チェックポイント阻害剤との併用療法の統合、個別化医療アプローチ、臨床試験の情勢の拡大、規制上のサポートとガイドラインの増加により予想されます。予測される重要な動向には、送達システムの技術進歩、合成生物学の進歩、生物医薬品分野での協力と提携、ウイルス学と免疫学の進歩、小児腫瘍学への集中的なアプローチが含まれます。

がんの罹患率の増加は、腫瘍溶解性ウイルス治療市場の成長を促進する態勢が整っています。がんは、制御されない細胞増殖を特徴とする病気の総称であり、世界の健康上の重大な懸念事項です。 腫瘍溶解性ウイルス治療は、がん細胞を選択的に標的にして排除すると同時に腫瘍に対する免疫反応を引き起こし、効果的ながん治療のための二重のメカニズムを提供する、有望なアプローチとして浮上しています。特に、2023年 1月、米国がん協会は、2022年の米国におけるがんによる死亡者数は609,820人、新たながん症例数は1,958,310人になると予測しました。この厳しい現実は、がんの蔓延の増加に対処するために、腫瘍溶解性ウイルス治療などの革新的な治療アプローチががんの場合緊急に必要であることを強調しています。

腫瘍溶解性ウイルス治療市場は、進行中の臨床試験の数の増加により成長が見込まれています。臨床試験は、人間の参加者を対象とした重要な調査であり、新しい治療法、介入、または診断手順の安全性と有効性を評価するのに役立ちます。 腫瘍溶解性ウイルス治療を利用した臨床試験の急増は、健康な組織を温存しながらがん細胞を選択的に標的とする能力を考慮すると、このアプローチの治療可能性を強調しています。 ClinicalTrials.govは、2023年 10月の時点で登録研究数が大幅に増加し、米国の50州すべてと221か国で2022年の437,523件から468,457件に増加したと報告しています。特に、143,613件の研究（全体の31%）が米国で登録されており、251,159件の研究（全体の54%）が米国以外の場所で登録されています。この臨床試験の急増は、がん治療の有望な手段として腫瘍溶解性ウイルス治療への関心と投資が高まっていることを意味しており、市場の拡大に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の腫瘍溶解性ウイルス治療市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の腫瘍溶解性ウイルス治療市場規模実績と成長、2018年から2023年
  • 世界の腫瘍溶解性ウイルス治療市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の腫瘍溶解性ウイルス治療市場、治療タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • HSVベースの腫瘍溶解性ウイルス治療
  • アデノウイルスに基づく腫瘍溶解性ウイルス療法
  • レオウイルス
  • ポックスウイルス
  • ニューカッスル病ウイルス（NDV）
  • その他の治療法
  • 世界の腫瘍溶解性ウイルス治療市場、ウイルスの種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 遺伝子組み換え腫瘍溶解性ウイルス
  • 腫瘍溶解性野生型ウイルス
  • 世界の腫瘍溶解性ウイルス治療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 悪性黒色腫
  • 脳腫瘍
  • 血液がん
  • 世界の腫瘍溶解性ウイルス治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • がん調査機関

第7章 地域および国の分析

  • 世界の腫瘍溶解性ウイルス治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の腫瘍溶解性ウイルス治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 腫瘍溶解性ウイルス治療市場の競合情勢
  • 腫瘍溶解性ウイルス治療市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Sorrento Therapeutics Inc.
    • AbbVie Inc.
    • AstraZeneca plc

第31章 その他の大手および革新的な企業

  • Amgen Inc.
  • Boehringer Ingelheim Group
  • Regeneron Pharmaceuticals
  • Daiichi Sankyo Company Limited
  • Eurofins Scientific SE
  • Recipharm AB
  • Kissei Pharmaceutical Co. Ltd.
  • Takara Bio Inc.
  • Oncorus Inc.
  • Replimune Inc.
  • Vyriad Inc.
  • Genelux Corporation
  • Oncolys BioPharma Inc.
  • Adze Biotechnology
  • Oncolytics Biotech Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14023

Oncolytic virus therapy, also referred to as virotherapy, represents a cancer treatment approach employing viruses to selectively target and eliminate cancer cells within the body. The primary goal of this therapy is to leverage modified or naturally occurring viruses capable of infecting and replicating specifically within cancerous cells while preserving healthy cells.

The key categories of oncolytic virus therapy include HSV-based oncolytic virus therapy, adenovirus-based oncolytic virus therapy, reovirus, poxviruses, Newcastle disease virus (NDV), among others. HSV-based oncolytic virus therapy employs the herpes simplex virus (HSV) as the foundational component for treatment. Various virus types encompass genetically modified oncolytic viruses as well as oncolytic wild-type viruses. These therapies find application across different cancer types such as breast cancer, lung cancer, prostate cancer, melanoma, brain tumors, and blood cancer. They are utilized by healthcare institutions including hospitals, specialized clinics, and cancer research institutes.

The oncolytic virus therapy market research report is one of a series of new reports from The Business Research Company that provides oncolytic virus therapy market statistics, including oncolytic virus therapy industry global market size, regional shares, competitors with an oncolytic virus therapy market share, detailed oncolytic virus therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the oncolytic virus therapy industry. This oncolytic virus therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncolytic virus therapy market size has grown exponentially in recent years. It will grow from $0.15 billion in 2023 to $0.19 billion in 2024 at a compound annual growth rate (CAGR) of 26.2%. Historical growth stemmed from enhanced genetic engineering methods, heightened comprehension of the tumor microenvironment, successful clinical outcomes, regulatory endorsements, and the prominence of immunotherapy in cancer care, alongside progress in gene delivery systems.

The oncolytic virus therapy market size is expected to see exponential growth in the next few years. It will grow to $0.44 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. The anticipated growth in the upcoming period is expected due to the broadening of oncolytic virus platforms, the integration of combination therapies with immune checkpoint inhibitors, personalized medicine approaches, the widening landscape of clinical trials, and increased regulatory support and guidelines. Significant trends projected include technological advancements in delivery systems, progress in synthetic biology, collaborations and partnerships within the biopharmaceutical sector, advancements in virology and immunology, and a focused approach on pediatric oncology.

The escalating prevalence of cancer cases stands poised to drive the growth of the oncolytic virus therapy market. Cancer, a collective term for diseases characterized by uncontrolled cell growth, is a significant global health concern. Oncolytic virus therapy emerges as a promising approach, capable of selectively targeting and eliminating cancer cells while simultaneously triggering an immune response against tumors, providing a dual mechanism for effective cancer treatment. Notably, in January 2023, the American Cancer Society Inc. projected 609,820 cancer deaths and 1,958,310 new cancer cases in the United States for 2022. This stark reality underscores the urgent need for innovative therapeutic approaches, such as oncolytic virus therapy, to address the growing prevalence of cancer cases.

The oncolytic virus therapy market is expected to experience growth propelled by the increasing number of ongoing clinical trials. Clinical trials, essential research studies involving human participants, serve to assess the safety and efficacy of new medical treatments, interventions, or diagnostic procedures. The surge in clinical trials utilizing oncolytic virus therapy underscores the therapeutic potential of this approach, given its ability to selectively target cancer cells while sparing healthy tissue. As of October 2023, ClinicalTrials.gov reported a significant increase in registered studies, rising from 437,523 in 2022 to 468,457 across all 50 states of the United States and 221 countries. Notably, 143,613 studies (31% of the total) are registered in the U.S., with 251,159 studies (54% of the total) registered in non-U.S. locations. This proliferation of clinical trials signifies the growing interest and investment in oncolytic virus therapy as a promising avenue for cancer treatment, contributing to the market's expansion.

Product innovations emerge as a central trend gaining momentum, with major companies strategically focusing on the introduction of groundbreaking products to fortify their market standing. A notable example is Daiichi Sankyo Company Limited, a Japan-based pharmaceutical company, which launched DELYTACT in Japan in November 2021. DELYTACT represents a significant milestone as the first oncolytic virus approved for primary brain cancer globally, featuring a genetically engineered oncolytic herpes simplex virus type 1 (HSV-1). This innovative therapy operates by selectively replicating and eliminating tumor cells while sparing normal tissues, showcasing the transformative potential of oncolytic virus therapy in cancer treatment.

Strategic partnerships play a pivotal role in advancing comprehensive cancer treatments within the oncolytic virus therapy industry. RenovoRx Inc., a US-based clinical-stage biopharmaceutical company, and Imugene Ltd., an Australia-based clinical-stage immuno-oncology company, forged a strategic research collaboration in July 2023. The aim of this partnership is to optimize the delivery of Imugene's oncolytic virus therapy leveraging RenovoRx's TAMP (Trans-Arterial Micro-Perfusion) therapy platform. Additionally, the collaboration seeks to explore the administration of Imugene's CF33 oncolytic virus technology using RenovoRx's TAMP therapy platform, with a specific focus on treating challenging-to-access tumors. This strategic alliance exemplifies the industry's commitment to collaborative efforts, driving advancements in oncolytic virus therapy for enhanced cancer treatment outcomes.

In April 2022, Recipharm AB, a pharmaceutical company based in Sweden, completed the acquisition of Vibalogics for an undisclosed sum. This strategic move enabled Recipharm AB to enhance its global presence significantly by integrating a comprehensive end-to-end portfolio encompassing development capabilities, GMP drug substance and drug product manufacturing, sterile fill & finish services, as well as analytical and quality control testing. Vibalogics, a German biotechnology firm and a Contract Development and Manufacturing Organization (CDMO), specializes in manufacturing oncolytic viruses, viral vaccines, and gene therapies.

Major companies operating in the oncolytic virus therapy market report are Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca plc, Amgen Inc., Boehringer Ingelheim Group, Regeneron Pharmaceuticals, Daiichi Sankyo Company Limited, Eurofins Scientific SE, Recipharm AB, Kissei Pharmaceutical Co. Ltd., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Adze Biotechnology, Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Circio Holding ASA, Lokon Pharma AB, Provectus Biopharmaceuticals Inc., Vibalogics, SillaJen Inc.

North America was the largest region in the oncolytic virus therapy market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncolytic virus therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The oncolytic virus therapy market includes revenues earned by entities by providing seneca valley virus (SVV), semliki forest virus (SFV), vesicular stomatitis virus (VSV), and sindbis virus (SBV). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncolytic Virus Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncolytic virus therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncolytic virus therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncolytic virus therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Therapy Type: HSV-Based Oncolytic Virus Therapy; Adenovirus-Based Oncolytic Virus Therapy; Reovirus; Poxviruses; NDV (Newcastle Disease Virus); Other Therapy Types
  • 2) By Virus Type: Genetically Engineered Oncolytic Viruses; Oncolytic Wild-Type Viruses
  • 3) By Application: Breast Cancer; Lung Cancer; Prostate Cancer; Melanoma; Brain Tumor; Blood Cancer
  • 4) By End-User: Hospitals; Specialty Clinics; Cancer Research Institutes
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Sorrento Therapeutics Inc.; AbbVie Inc.; AstraZeneca plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oncolytic Virus Therapy Market Characteristics

3. Oncolytic Virus Therapy Market Trends And Strategies

4. Oncolytic Virus Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Oncolytic Virus Therapy Market Size and Growth

  • 5.1. Global Oncolytic Virus Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Oncolytic Virus Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Oncolytic Virus Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oncolytic Virus Therapy Market Segmentation

  • 6.1. Global Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • HSV-Based Oncolytic Virus Therapy
  • Adenovirus-Based Oncolytic Virus Therapy
  • Reovirus
  • Poxviruses
  • Newcastle Disease Virus (NDV)
  • Other Therapy Types
  • 6.2. Global Oncolytic Virus Therapy Market, Segmentation By Virus Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genetically Engineered Oncolytic Viruses
  • Oncolytic Wild-Type Viruses
  • 6.3. Global Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Melanoma
  • Brain Tumor
  • Blood Cancer
  • 6.4. Global Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Cancer Research Institutes

7. Oncolytic Virus Therapy Market Regional And Country Analysis

  • 7.1. Global Oncolytic Virus Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Oncolytic Virus Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oncolytic Virus Therapy Market

  • 8.1. Asia-Pacific Oncolytic Virus Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oncolytic Virus Therapy Market

  • 9.1. China Oncolytic Virus Therapy Market Overview
  • 9.2. China Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oncolytic Virus Therapy Market

  • 10.1. India Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oncolytic Virus Therapy Market

  • 11.1. Japan Oncolytic Virus Therapy Market Overview
  • 11.2. Japan Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oncolytic Virus Therapy Market

  • 12.1. Australia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oncolytic Virus Therapy Market

  • 13.1. Indonesia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oncolytic Virus Therapy Market

  • 14.1. South Korea Oncolytic Virus Therapy Market Overview
  • 14.2. South Korea Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oncolytic Virus Therapy Market

  • 15.1. Western Europe Oncolytic Virus Therapy Market Overview
  • 15.2. Western Europe Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oncolytic Virus Therapy Market

  • 16.1. UK Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oncolytic Virus Therapy Market

  • 17.1. Germany Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oncolytic Virus Therapy Market

  • 18.1. France Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oncolytic Virus Therapy Market

  • 19.1. Italy Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oncolytic Virus Therapy Market

  • 20.1. Spain Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oncolytic Virus Therapy Market

  • 21.1. Eastern Europe Oncolytic Virus Therapy Market Overview
  • 21.2. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oncolytic Virus Therapy Market

  • 22.1. Russia Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oncolytic Virus Therapy Market

  • 23.1. North America Oncolytic Virus Therapy Market Overview
  • 23.2. North America Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oncolytic Virus Therapy Market

  • 24.1. USA Oncolytic Virus Therapy Market Overview
  • 24.2. USA Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oncolytic Virus Therapy Market

  • 25.1. Canada Oncolytic Virus Therapy Market Overview
  • 25.2. Canada Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oncolytic Virus Therapy Market

  • 26.1. South America Oncolytic Virus Therapy Market Overview
  • 26.2. South America Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oncolytic Virus Therapy Market

  • 27.1. Brazil Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oncolytic Virus Therapy Market

  • 28.1. Middle East Oncolytic Virus Therapy Market Overview
  • 28.2. Middle East Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oncolytic Virus Therapy Market

  • 29.1. Africa Oncolytic Virus Therapy Market Overview
  • 29.2. Africa Oncolytic Virus Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Oncolytic Virus Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Oncolytic Virus Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oncolytic Virus Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Oncolytic Virus Therapy Market Competitive Landscape
  • 30.2. Oncolytic Virus Therapy Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sorrento Therapeutics Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AstraZeneca plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Oncolytic Virus Therapy Market Other Major And Innovative Companies

  • 31.1. Amgen Inc.
  • 31.2. Boehringer Ingelheim Group
  • 31.3. Regeneron Pharmaceuticals
  • 31.4. Daiichi Sankyo Company Limited
  • 31.5. Eurofins Scientific SE
  • 31.6. Recipharm AB
  • 31.7. Kissei Pharmaceutical Co. Ltd.
  • 31.8. Takara Bio Inc.
  • 31.9. Oncorus Inc.
  • 31.10. Replimune Inc.
  • 31.11. Vyriad Inc.
  • 31.12. Genelux Corporation
  • 31.13. Oncolys BioPharma Inc.
  • 31.14. Adze Biotechnology
  • 31.15. Oncolytics Biotech Inc.

32. Global Oncolytic Virus Therapy Market Competitive Benchmarking

33. Global Oncolytic Virus Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Oncolytic Virus Therapy Market

35. Oncolytic Virus Therapy Market Future Outlook and Potential Analysis

  • 35.1 Oncolytic Virus Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Oncolytic Virus Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Oncolytic Virus Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer